Document is current
Any future updates will be listed below
-
Authors
Mishima, Eikan https://orcid.org/0000-0002-3706-2745
Nakamura, Toshitaka https://orcid.org/0000-0002-4248-2058
Doll, Sebastian
Proneth, Bettina https://orcid.org/0000-0002-4119-9437
Fedorova, Maria
Pratt, Derek A.
Friedmann Angeli, José Pedro
Dixon, Scott J. https://orcid.org/0000-0001-6230-8199
Wahida, Adam
Conrad, Marcus https://orcid.org/0000-0003-1140-5612
- License Information
-
More Information
Article History
Accepted: 27 February 2025
First Online: 9 April 2025
Competing interests
: M.C. and B.P. are cofounders and shareholders of ROSCUE Therapeutics GmbH. D.A.P. is a cofounder and shareholder of Prothegen Inc. S.J.D. holds patents related to ferroptosis. M.C., B.P. and T.N. have filed patents for some of the compounds described herein.
